Status:
COMPLETED
Symbicort in Asthmatic Children - SEEDLING
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
6-11 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare Symbicort with budesonide alone and formoterol alone in the treatment of asthma in children aged 6 to 11 years
Eligibility Criteria
Inclusion
- Baseline lung function tests results as determined by the protocol
- Required and received treatment with inhaled corticosteroids within the timeframe and doses specified in the protocol
Exclusion
- Has required treatment with non-inhaled corticosteroids within previous 4 weeks, has sensitivity to drugs specified in the protocol or requires treatment with beta-blockers
- Has been hospitalised or required emergency treatment for asthma-related condition within previous 6 months
- Has had cancer within previous 5 years or has a significant disease, as judged by investigator, that may put the patient at risk in this study
Key Trial Info
Start Date :
July 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2003
Estimated Enrollment :
405 Patients enrolled
Trial Details
Trial ID
NCT00651547
Start Date
July 1 2002
End Date
October 1 2003
Last Update
March 30 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.